ProQR Therapeutics N.V. PRQR
1.10 USD -0.05 (-4.35%)
Regular-session close
1.10 0.00 0.00%
After hours · Nov 18, 4:00 PM ET
1.07 Day range 1.17
1.07 52-week range 2.49
- YTD
- -45.54%
- 1 year
- -47.12%
News
benzinga.com ProQR Therapeutics Q3 EPS $(0.10) Beats $(0.11) Estimate, Sales $5.933M Beat $5.350M Estimate ProQR Therapeutics (NASDAQ:PRQR) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.11) by 9.09 percent. This is a 9.09 percent increase over losses of…
globenewswire.com ProQR Announces Third Quarter 2026 Operating and Financial Results Fully enrolled Cohorts 1 and 2 of AX-0811 Phase 1 trial; initial target engagement data expected in early January 2027 Full AX-0810 Phase 1 dataset, including Cohort 3 and follow-up data, and new…benzinga.com ProQR Therapeutics To Present Data On Its AX-0810, AX-0811 At The Liver Meeting 2026, Nature Conferences RNA ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a clinical-stage company dedicated to changing lives through transformative RNA therapies based on its proprietary ADAR-mediated Axiomer™ RNA editing…
